Export 2096 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is C  [Clear All Filters]
2022
D. S. Carrell, Cronkite, D. J., Shea, M., Oliver, M., Luce, C., Matson, T. E., Bobb, J. F., Hsu, C., Binswanger, I. A., Browne, K. C., Saxon, A. J., McCormack, J., Jelstrom, E., Ghitza, U. E., Campbell, C. I., Bradley, K. A., and Lapham, G. T., Clinical Documentation of Patient-Reported Medical Cannabis Use in Primary Care: Toward Scalable Extraction Using Natural Language Processing Methods, Subst Abus, vol. 43, no. 1, pp. 917-924, 2022.
D. S. Carrell, Cronkite, D. J., Shea, M., Oliver, M., Luce, C., Matson, T. E., Bobb, J. F., Hsu, C., Binswanger, I. A., Browne, K. C., Saxon, A. J., McCormack, J., Jelstrom, E., Ghitza, U. E., Campbell, C. I., Bradley, K. A., and Lapham, G. T., Clinical Documentation of Patient-Reported Medical Cannabis Use in Primary Care: Toward Scalable Extraction Using Natural Language Processing Methods, Subst Abus, vol. 43, no. 1, pp. 917-924, 2022.
D. S. Carrell, Cronkite, D. J., Shea, M., Oliver, M., Luce, C., Matson, T. E., Bobb, J. F., Hsu, C., Binswanger, I. A., Browne, K. C., Saxon, A. J., McCormack, J., Jelstrom, E., Ghitza, U. E., Campbell, C. I., Bradley, K. A., and Lapham, G. T., Clinical Documentation of Patient-Reported Medical Cannabis Use in Primary Care: Toward Scalable Extraction Using Natural Language Processing Methods, Subst Abus, vol. 43, no. 1, pp. 917-924, 2022.
H. Schöder, Hope, T. A., Knopp, M., Kelly, W. K., Michalski, J. M., Lerner, S. P., Tawab-Amiri, A., Mann, B. S., Lin, D. W., Yu, E. Y., Chen, R. C., Beach, G. C., Reeves, S. A., and Shankar, L. K., Considerations on Integrating Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging Into Clinical Prostate Cancer Trials by National Clinical Trials Network Cooperative Groups, J Clin Oncol, vol. 40, no. 13, pp. 1500-1505, 2022.
P. L. Wander, Hinkle, S. N., Enquobahrie, D. A., Wu, J., Ley, S. H., Grunnet, L. G., Chavarro, J. E., Li, M., Bjerregaard, A. A., Liu, A., Damm, P., Sherman, S., Rawal, S., Zhu, Y., Chen, L., Mills, J. L., Hu, F. B., Vaag, A., Olsen, S. F., and Zhang, C., Cumulative Lactation and Clinical Metabolic Outcomes at Mid-Life among Women with a History of Gestational Diabetes, Nutrients, vol. 14, no. 3, 2022.
P. L. Wander, Hinkle, S. N., Enquobahrie, D. A., Wu, J., Ley, S. H., Grunnet, L. G., Chavarro, J. E., Li, M., Bjerregaard, A. A., Liu, A., Damm, P., Sherman, S., Rawal, S., Zhu, Y., Chen, L., Mills, J. L., Hu, F. B., Vaag, A., Olsen, S. F., and Zhang, C., Cumulative Lactation and Clinical Metabolic Outcomes at Mid-Life among Women with a History of Gestational Diabetes, Nutrients, vol. 14, no. 3, 2022.
K. M. Job, Dallmann, A., Parry, S., Saade, G., Haas, D. M., Hughes, B., Berens, P., Chen, J. - Y., Fu, C., Humphrey, K., Hornik, C., Balevic, S., Zimmerman, K., and Watt, K., Development of a Generic Physiologically-Based Pharmacokinetic Model for Lactation and Prediction of Maternal and Infant Exposure to Ondansetron via Breast Milk, Clin Pharmacol Ther, vol. 5, 2022.
N. Rouphael, Beck, A., Kirby, A. E., Liu, P., Natrajan, M. S., Lai, L., Phadke, V., Winston, J., Raabe, V., Collins, M. H., Girmay, T., Alvarez, A., Beydoun, N., Karmali, V., Altieri-Rivera, J., Lindesmith, L. C., Anderson, E. J., Wang, Y., El-Khorazaty, J., Petrie, C., Baric, R. S., Baqar, S., Moe, C. L., and Mulligan, M. J., Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model Inoculum, J Infect Dis, vol. 226, no. 10, pp. 1771-1780, 2022.
M. H. Collins, Potter, G. E., Hitchings, M. D. T., Butler, E., Wiles, M., Kennedy, J. K., Pinto, S. B., Teixeira, A. B. M., Casanovas-Massana, A., Rouphael, N. G., Deye, G. A., Simmons, C. P., Moreira, L. A., Nogueira, M. L., Cummings, D., Ko, A., Teixeira, M. M., and Edupuganti, S., EVITA Dengue: a Cluster-Randomized Controlled Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral Infection in Brazil, Trials, vol. 23, no. 1, p. 185, 2022.
M. H. Collins, Potter, G. E., Hitchings, M. D. T., Butler, E., Wiles, M., Kennedy, J. K., Pinto, S. B., Teixeira, A. B. M., Casanovas-Massana, A., Rouphael, N. G., Deye, G. A., Simmons, C. P., Moreira, L. A., Nogueira, M. L., Cummings, D., Ko, A., Teixeira, M. M., and Edupuganti, S., EVITA Dengue: a Cluster-Randomized Controlled Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral Infection in Brazil, Trials, vol. 23, no. 1, p. 185, 2022.
M. H. Collins, Potter, G. E., Hitchings, M. D. T., Butler, E., Wiles, M., Kennedy, J. K., Pinto, S. B., Teixeira, A. B. M., Casanovas-Massana, A., Rouphael, N. G., Deye, G. A., Simmons, C. P., Moreira, L. A., Nogueira, M. L., Cummings, D., Ko, A., Teixeira, M. M., and Edupuganti, S., EVITA Dengue: a Cluster-Randomized Controlled Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral Infection in Brazil, Trials, vol. 23, no. 1, p. 185, 2022.
S. M. Raja, Guptill, J. T., Juel, V. C., Walter, E. B., Cohen-Wolkowiez, M., Hill, H., Sendra, E., Hauser, B., Jackson, P., Tomic, M., Espinoza, Y., and Swamy, G. K., First-in-Human Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Single Doses of NTM-1633, a Novel Mixture of Monoclonal Antibodies against Botulinum Toxin E, Antimicrob Agents Chemother, vol. 66, no. 4, p. e0173221, 2022.
A. Vena, Cao, D., and King, A., Frontloading In The Real-World: Leveraging Smartphone Technology To Examine Rate Of Alcohol Consumption Effects On Subjective Responses In Heavy Drinkers, in 45th Annual Speaker & Poster Abstracts of the Research Society on Alcoholism, Orlando, Florida, 2022.
T. P Korthuis, Cook, R. R., Lum, P. J., Waddell, E. Needham, Tookes, H., Vergara-Rodriguez, P., Kunkel, L. E., Lucas, G. M., Rodriguez, A. E., Bielavitz, S., Fanucchi, L. C., Hoffman, K. A., Bachrach, K., Payne, E. H., Collins, J. A., Matthews, A., Oden, N., Jacobs, P., Jelstrom, E., Sorensen, J. L., and McCarty, D., HIV Clinic-based Extended-release Naltrexone versus Treatment as Usual for People with HIV and Opioid Use Disorder: a Non-blinded, Randomized Non-inferiority Trial, Addiction, vol. 117, no. 7, pp. 1961-1971, 2022.
T. P Korthuis, Cook, R. R., Lum, P. J., Waddell, E. Needham, Tookes, H., Vergara-Rodriguez, P., Kunkel, L. E., Lucas, G. M., Rodriguez, A. E., Bielavitz, S., Fanucchi, L. C., Hoffman, K. A., Bachrach, K., Payne, E. H., Collins, J. A., Matthews, A., Oden, N., Jacobs, P., Jelstrom, E., Sorensen, J. L., and McCarty, D., HIV Clinic-based Extended-release Naltrexone versus Treatment as Usual for People with HIV and Opioid Use Disorder: a Non-blinded, Randomized Non-inferiority Trial, Addiction, vol. 117, no. 7, pp. 1961-1971, 2022.
G. Meyers, Hamadani, M., Martens, M., Ali, H., Choe, H., Dawson, P., Harris, A. C., van Hooren, E., Klaassen, W., Leifer, E., MacMillan, M. L., van Oosterhout, Y., Perez, L., Pusic, I., Vo, P., and Levine, J. E., Lessons Learned from Early Closure of a Clinical Trial for Steroid-refractory Acute GVHD, Bone Marrow Transplant, vol. 57, no. 2, pp. 302-303, 2022.
D. R. Stevens, Rohn, M. C. H., Hinkle, S. N., Williams, A. D., Kumar, R., Lipsky, L. M., Grobman, W., Sherman, S., Kanner, J., Chen, Z., and Mendola, P., Maternal Body Composition and Gestational Weight Gain in Relation to Asthma Control During Pregnancy, PLoS One, vol. 17, no. 4, p. e0267122, 2022.
N. S. Karnik, Marsden, J., McCluskey, C., Boley, R. A., Bradley, K. A., Campbell, C. I., Curtis, M. E., Fiellin, D., Ghitza, U., Hefner, K., Hser, Y. - I., R McHugh, K., McPherson, S. M., Mooney, L. J., Moran, L. M., Murphy, S. M., Schwartz, R. P., Shmueli-Blumberg, D., Shulman, M., Stephens, K. A., Watkins, K. E., Weiss, R. D., and Wu, L. - T., The Opioid Use Disorder Core Outcomes Set (OUD-COS) for Treatment Research: Findings from a Delphi Consensus Study, Addiction, vol. 17, no. 9, pp. 2438-2447, 2022.
N. S. Karnik, Marsden, J., McCluskey, C., Boley, R. A., Bradley, K. A., Campbell, C. I., Curtis, M. E., Fiellin, D., Ghitza, U., Hefner, K., Hser, Y. - I., R McHugh, K., McPherson, S. M., Mooney, L. J., Moran, L. M., Murphy, S. M., Schwartz, R. P., Shmueli-Blumberg, D., Shulman, M., Stephens, K. A., Watkins, K. E., Weiss, R. D., and Wu, L. - T., The Opioid Use Disorder Core Outcomes Set (OUD-COS) for Treatment Research: Findings from a Delphi Consensus Study, Addiction, vol. 17, no. 9, pp. 2438-2447, 2022.
K. E. Trocin, Oga, E. A., Mulatya, C., Mark, K. S., and Coleman-Cowger, V. H., Patient Perceptions of Three Substance Use Screening Tools for Use During Pregnancy, Matern Child Health J, vol. 26, no. 7, pp. 1488-1495, 2022.
R. G. Greenberg, Landersdorfer, C. B., Rivera-Chaparro, N., Harward, M., Conrad, T., Nakamura, A., Kirkpatrick, C. M., Gu, K., Ghazaryhan, V., Osborn, B., and Walter, E. B., Population Pharmacokinetics of Moxifloxacin in Children, Paediatr Drugs, vol. 24, no. 2, pp. 163-173, 2022.
C. Byrnes, Botello-Harbaum, M., Clemons, T., Bailey, L., Valdes, K. M., and Coleman-Cowger, V. H., Process and Strategies for Patient Engagement and Outreach in the Sickle Cell Disease (SCD) Community to Promote Clinical Trial Participation, J Natl Med Assoc, vol. 114, no. 2, pp. 211-217, 2022.
C. Byrnes, Botello-Harbaum, M., Clemons, T., Bailey, L., Valdes, K. M., and Coleman-Cowger, V. H., Process and Strategies for Patient Engagement and Outreach in the Sickle Cell Disease (SCD) Community to Promote Clinical Trial Participation, J Natl Med Assoc, vol. 114, no. 2, pp. 211-217, 2022.
K. Trocin, Oga, E. A., Mulatya, C., Mark, K. S., and Coleman-Cowger, V. H., Qualitative Results from NIDA Grant, Maternal Child Health, vol. 26, no. 7, 2022.
E. E. Coates, Edupuganti, S., Chen, G. L., Happe, M., Strom, L., Widge, A., Florez, M. Burgos, Cox, J. H., Gordon, I., Plummer, S., Ola, A., Yamshchikov, G., Andrews, C., Curate-Ingram, S., Morgan, P., Nagar, S., Collins, M. H., Bray, A., Nguyen, T., Stein, J., Case, C. L., Kaltovich, F., Wycuff, D., C Liang, J., Carlton, K., Vazquez, S., Mascola, J. R., and Ledgerwood, J. E., Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial., Lancet Infect Dis, vol. 22, no. 8, pp. 1210-1220, 2022.